Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials.

Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RG, de Craen AJ, Knopp RH, Nakamura H, Ridker P, van Domburg R, Deckers JW.

BMJ. 2009 Jun 30;338:b2376. doi: 10.1136/bmj.b2376. Review.

PMID:
19567909
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis.

de Vries FM, Denig P, Pouwels KB, Postma MJ, Hak E.

Drugs. 2012 Dec 24;72(18):2365-73. doi: 10.2165/11638240-000000000-00000. Review.

PMID:
23186103
[PubMed - indexed for MEDLINE]
3.

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I.

Lancet. 2010 Feb 27;375(9716):735-42. doi: 10.1016/S0140-6736(09)61965-6. Epub 2010 Feb 16.

PMID:
20167359
[PubMed - indexed for MEDLINE]
4.

The causes and effects of socio-demographic exclusions from clinical trials.

Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P.

Health Technol Assess. 2005 Oct;9(38):iii-iv, ix-x, 1-152. Review.

PMID:
16181564
[PubMed - indexed for MEDLINE]
Free Article
5.

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.

Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC.

BMJ. 2008 Mar 22;336(7645):645-51. doi: 10.1136/bmj.39472.580984.AE. Epub 2008 Feb 25. Review. Erratum in: BMJ. 2009;339:b2951.

PMID:
18299289
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

PMID:
17408535
[PubMed - indexed for MEDLINE]
Free Article
7.

Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes.

Cheung BM, Lauder IJ, Lau CP, Kumana CR.

Br J Clin Pharmacol. 2004 May;57(5):640-51.

PMID:
15089818
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis.

Tonelli M, Lloyd A, Clement F, Conly J, Husereau D, Hemmelgarn B, Klarenbach S, McAlister FA, Wiebe N, Manns B; Alberta Kidney Disease Network.

CMAJ. 2011 Nov 8;183(16):E1189-202. doi: 10.1503/cmaj.101280. Epub 2011 Oct 11. Review.

PMID:
21989464
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis.

Chen YH, Feng B, Chen ZW.

Exp Clin Endocrinol Diabetes. 2012 Feb;120(2):116-20. doi: 10.1055/s-0031-1297968. Epub 2011 Dec 20. Review.

PMID:
22187291
[PubMed - indexed for MEDLINE]
10.

Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.

Naci H, Brugts J, Ades T.

Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):390-9. doi: 10.1161/CIRCOUTCOMES.111.000071. Epub 2013 Jul 9. Review.

PMID:
23838105
[PubMed - indexed for MEDLINE]
Free Article
11.

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.

Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N.

Lancet. 2009 May 23;373(9677):1765-72. doi: 10.1016/S0140-6736(09)60697-8.

PMID:
19465231
[PubMed - indexed for MEDLINE]
12.

Efficacy and safety of statin monotherapy in older adults: a meta-analysis.

Roberts CG, Guallar E, Rodriguez A.

J Gerontol A Biol Sci Med Sci. 2007 Aug;62(8):879-87. Review.

PMID:
17702880
[PubMed - indexed for MEDLINE]
13.

Meta-analysis of effect of statin treatment on risk of sudden death.

Levantesi G, Scarano M, Marfisi R, Borrelli G, Rutjes AW, Silletta MG, Tognoni G, Marchioli R.

Am J Cardiol. 2007 Dec 1;100(11):1644-50. Epub 2007 Oct 24.

PMID:
18036362
[PubMed - indexed for MEDLINE]
14.

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK.

JAMA. 2011 Jun 22;305(24):2556-64. doi: 10.1001/jama.2011.860.

PMID:
21693744
[PubMed - indexed for MEDLINE]
15.

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

Vrecer M, Turk S, Drinovec J, Mrhar A.

Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.

PMID:
14692706
[PubMed - indexed for MEDLINE]
16.

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.

Hou W, Lv J, Perkovic V, Yang L, Zhao N, Jardine MJ, Cass A, Zhang H, Wang H.

Eur Heart J. 2013 Jun;34(24):1807-17. doi: 10.1093/eurheartj/eht065. Epub 2013 Mar 6. Review.

PMID:
23470492
[PubMed - indexed for MEDLINE]
Free Article
17.

"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24.

PMID:
20550659
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.

Rahimi K, Emberson J, McGale P, Majoni W, Merhi A, Asselbergs FW, Krane V, Macfarlane PW; PROSPER Executive.

BMJ. 2011 Mar 16;342:d1250. doi: 10.1136/bmj.d1250.

PMID:
21411487
[PubMed - indexed for MEDLINE]
Free Article
19.

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesäniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M; FIELD study investigators.

Lancet. 2005 Nov 26;366(9500):1849-61. Erratum in: Lancet. 2006 Oct 21;368(9545):1415. Lancet. 2006 Oct 21;368(9545):1420.

PMID:
16310551
[PubMed - indexed for MEDLINE]
20.

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.

Cholesterol Treatment Trialists' (CTT) Collaborators, Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, Armitage J, Baigent C.

Lancet. 2008 Jan 12;371(9607):117-25. doi: 10.1016/S0140-6736(08)60104-X.

PMID:
18191683
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk